Hormone Therapy in the Era of the COVID-19 Pandemic: A Review

    January 2022 in “ Journal of Menopausal Medicine ”
    Sung Wook Choi, Juhee Kim, Jae Hoon Lee, Seul Ki Kim, Sa Ra Lee, Sung Hoon Kim, Hee Dong Chae
    TLDR Careful medical care is needed for those over 50 on hormone therapy during COVID-19.
    The review discussed the impact of the COVID-19 pandemic on hormone therapy, particularly in the context of gynecology. It highlighted the virus's ability to affect various body systems, including the endocrine system, and emphasized the need for careful medical care for individuals over 50 due to higher fatality rates. Despite the importance of hormone therapy, the review noted a lack of high-quality evidence for individualized management during the pandemic. The document aimed to provide a reference for clinical application by analyzing existing studies on female hormone therapy in the COVID-19 context.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results